Identification and characterization of m1 selective muscarinic receptor antagonists

被引:9
作者
Augelli-Szafran, CE
Blankley, CJ
Jaen, JC
Moreland, DW
Nelson, CB
Penvose-Yi, JR
Schwarz, RD
Thomas, AJ
机构
[1] Parke Davis Pharmaceut Res, Dept Med Chem, Ann Arbor, MI 48105 USA
[2] Parke Davis Pharmaceut Res, Dept Neurosci Therapeut, Ann Arbor, MI 48105 USA
关键词
D O I
10.1021/jm980067l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of esters of 1,4-disubstituted tetrahydropyridine carboxylic acids (I) has been synthesized and characterized as potential mi selective muscarinic receptor antagonists. The affinity of these compounds for the five human muscarinic receptor subtypes (Hm1-Hm5) was determined by the displacement of [H-3]-NMS binding using membranes from transfected Chinese hamster ovarian cells. One of the most potent and selective compounds of this series is an analogue of I [11, R-1 = (CH2)(5)CH3], which has an IC50 value of 27.3 nM at the m1 receptor and possesses 100-fold (m2), 48-fold (m3), 74-fold (m4), and 19-fold (m5) selectivities at the other receptors. Thus, this analogue appears to be more selective on the basis of binding than the prototypical mi antagonist, pirenzepine. Functional data, such as the inhibition of carbachol-stimulated phosphatidylinositol hydrolysis, on selected analogues confirmed the muscarinic antagonistic properties of this chemical series.
引用
收藏
页码:356 / 363
页数:8
相关论文
共 29 条
[1]  
AUGELLISZAFRAN CE, IDENTIFICATION CHARA
[2]   MUSCARINIC RECEPTOR SUBTYPES IN AIRWAYS [J].
BARNES, PJ ;
MINETTE, P ;
MACLAGAN, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (11) :412-416
[3]   LITHIUM AMPLIFIES AGONIST-DEPENDENT PHOSPHATIDYLINOSITOL RESPONSES IN BRAIN AND SALIVARY-GLANDS [J].
BERRIDGE, MJ ;
DOWNES, CP ;
HANLEY, MR .
BIOCHEMICAL JOURNAL, 1982, 206 (03) :587-595
[4]   INOSITOL TRISPHOSPHATE, A NOVEL 2ND MESSENGER IN CELLULAR SIGNAL TRANSDUCTION [J].
BERRIDGE, MJ ;
IRVINE, RF .
NATURE, 1984, 312 (5992) :315-321
[5]  
BOLDEN C, 1992, J PHARMACOL EXP THER, V260, P576
[6]  
BUCKLEY NJ, 1989, MOL PHARMACOL, V35, P469
[7]  
Caulfield MP, 1998, PHARMACOL REV, V50, P279
[8]  
COMINS DL, 1984, HETEROCYCLES, V22, P151
[9]   AF-DX 116 - A CARDIOSELECTIVE MUSCARINIC ANTAGONIST [J].
DOODS, HN ;
ENGEL, W ;
SU, CAPF ;
TANSWELL, P .
CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (01) :30-40
[10]  
DORJE F, 1991, J PHARMACOL EXP THER, V256, P727